HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: clinchem.2004.035519v1 50/11/2163    most recent Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Stöcher, M. Articles by Berg, J. Search for Related Content PubMed PubMed Citation Articles by Stöcher, M. Articles by Berg, J. Related Collections Molecular Diagnostics and Genetics

Internal Control DNA for PCR Assays Introduced into Lambda Phage Particles Exhibits Nuclease Resistance

Institute of Laboratory Medicine, General Hospital Linz, Krankenhausstrasse 9, A-4020 Linz, Austria

^aauthor for correspondence: fax 43-732-7806-1815, e-mail joerg.berg@akh.linz.at

The first 300 words of the full text of this article appear below.

Real-time PCR assays are widely used for the detection and quantification of pathogen-derived nucleic acids in clinical samples (1)(2)(3). Because clinical specimens contain PCR-inhibitory moieties that are not always reliably removed during nucleic acid extraction, real-time PCR assays are furnished with internal amplification controls (IACs) to identify those samples in which the PCR is inhibited (4)(5)(6)(7)(8)(9). Thus, false-negative test results or falsely diminished quantification results can be avoided.

For pathogen-specific real-time PCR assays, the IAC is usually added to clinical samples, recovered in the process of nucleic acid extraction, and amplified in either a multiplex or competitive fashion with detection usually by discrimination of hybridization probes (4)(5)(6)(7)(8)(9). Plasmid-derived DNA is commonly used as IAC. In this instance, the procedure does not provide entire control of PCR assays because the lysis of pathogens during the nucleic acid purification procedure is not monitored. Plasmid-derived IACs consist of bare, unprotected DNA; therefore, the IAC may become degraded within the clinical specimen before nucleic acid extraction or during storage in the working stock, which could lead to unreliable amplification of IAC DNA, necessitating repetition of testing.

In this report, we use a traditional lambda phage cloning procedure to generate phage particles containing target-specific IAC DNA, i.e., phage IAC. As IAC DNA we used the previously described multiple IAC that was generated for a panel of virus-specific real-time PCR assays with competitive IACs (10). We show that the obtained phage IAC contains one IAC DNA fragment, is resistant to DNase I digestion, and exhibits improved storage and handling properties as well as reliable amplification in the respective competitive real-time PCR assays.

The IAC . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				J. E. Gerriets, T. C. Greiner, and C. L. Gebhart Implementation of a T4 Extraction Control for Molecular Assays of Cerebrospinal Fluid and Stool Specimens J. Mol. Diagn., January 1, 2008; 10(1): 28 - 32. [Abstract] [Full Text] [PDF]

				A. Gotsch, A. Schubert, A. Bombis, M. Wiedmann, M. Zauke, and S. Schorling Nuclease-Resistant Single-Stranded DNA Controls for Nucleic Acid Amplification Assays J. Clin. Microbiol., August 1, 2007; 45(8): 2570 - 2574. [Abstract] [Full Text] [PDF]

				Y. Cheng, J. Niu, Y. Zhang, J. Huang, and Q. Li Preparation of His-Tagged Armored RNA Phage Particles as a Control for Real-Time Reverse Transcription-PCR Detection of Severe Acute Respiratory Syndrome Coronavirus. J. Clin. Microbiol., October 1, 2006; 44(10): 3557 - 3561. [Abstract] [Full Text] [PDF]

				C. Koidl, M. Bozic, J. Berg, M. Stocher, G. Muhlbauer, E. Marth, and H. H. Kessler Addition of a Homologous Internal Control to a Real-Time PCR Assay for Detection of Bordetella pertussis Clin. Chem., December 1, 2005; 51(12): 2404 - 2406. [Full Text] [PDF]

				C. R. WalkerPeach and B. L. Pasloske DNA Bacteriophage as Controls for Clinical Viral Testing Clin. Chem., November 1, 2004; 50(11): 1970 - 1971. [Full Text] [PDF]